Reasons for misdiagnosis of polymyositis in patients with dysferlinopathy: a clinical case

Differential diagnosis of inflammatory myopathies with hereditary muscular dystrophies accompanied by a secondary inflammatory process is a time‑consuming clinical and pathomorphological task. In particular, false diagnosis of polymyositis in patients with dysferlinopathy reaches 25 % of cases.A 40‑...

Full description

Saved in:
Bibliographic Details
Main Authors: S. N. Bardakov, A. М. Emelin, S. S. Nikitin, A. N. Khelkovskaya-Sergeeva, I. S. Limaev, A. F. Murtazina, V. A. Tsargush, M. V. Gusev, Ya. V. Safronova, V. S. Kaimonov, A. A. Isaev, R. V. Deev
Format: Article
Language:Russian
Published: ABV-press 2022-12-01
Series:Нервно-мышечные болезни
Subjects:
Online Access:https://nmb.abvpress.ru/jour/article/view/510
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025996100567040
author S. N. Bardakov
A. М. Emelin
S. S. Nikitin
A. N. Khelkovskaya-Sergeeva
I. S. Limaev
A. F. Murtazina
V. A. Tsargush
M. V. Gusev
Ya. V. Safronova
V. S. Kaimonov
A. A. Isaev
R. V. Deev
author_facet S. N. Bardakov
A. М. Emelin
S. S. Nikitin
A. N. Khelkovskaya-Sergeeva
I. S. Limaev
A. F. Murtazina
V. A. Tsargush
M. V. Gusev
Ya. V. Safronova
V. S. Kaimonov
A. A. Isaev
R. V. Deev
author_sort S. N. Bardakov
collection DOAJ
description Differential diagnosis of inflammatory myopathies with hereditary muscular dystrophies accompanied by a secondary inflammatory process is a time‑consuming clinical and pathomorphological task. In particular, false diagnosis of polymyositis in patients with dysferlinopathy reaches 25 % of cases.A 40‑year‑old female patient with a limb‑girdle phenotype of dysferlinopathy, initially diagnosed as polymyositis, is presented. The reasons that led to the erroneous diagnosis were: sporadic case; subacute onset; proximal muscle weakness; myalgia, which stopped on the glucocorticosteroid therapy; high levels of creatine phosphokinase (up to 17 times); the presence of lymphocytic‑macrophage infiltrate in the muscle biopsy and the absence of magnetic resonance imaging data in primary examination of the patient.The refractoriness of clinical and laboratory signs to complex immunosuppressive therapy was the reason for revising the muscle biopsy with typing of the inflammatory infiltrate. The predominantly unexpressed perivascular infiltrate was characterized by the predominance of macrophages and, to a lesser extent, CD4+, which indicated the secondary nature of the inflammation in the muscle observed in some hereditary muscular dystrophies. When conducting an immunohistochemical reaction, the absence of the dysferlin protein in the sarcoplasmic membrane was revealed.Whole‑exome sequencing (NGS) revealed a mutation in exon 39 of the DYSF gene (p.Gln1428Ter) in the heterozygous state, which leads to the appearance of a stop codon and premature termination of protein translation. MLPA method registered 3 copies of exons 18, 19, 20, 22, 24 of the DYSF gene.Thus, this clinical example reflects the main methodological errors and possible effects of immunosuppressive therapy in patients with dysferlinopathy.
format Article
id doaj-art-b2e69f02488b40eaa34fb3cd3cd8b162
institution DOAJ
issn 2222-8721
2413-0443
language Russian
publishDate 2022-12-01
publisher ABV-press
record_format Article
series Нервно-мышечные болезни
spelling doaj-art-b2e69f02488b40eaa34fb3cd3cd8b1622025-08-20T03:00:40ZrusABV-pressНервно-мышечные болезни2222-87212413-04432022-12-01124738710.17650/2222-8721-2022-12-4-73-87335Reasons for misdiagnosis of polymyositis in patients with dysferlinopathy: a clinical caseS. N. Bardakov0A. М. Emelin1S. S. Nikitin2A. N. Khelkovskaya-Sergeeva3I. S. Limaev4A. F. Murtazina5V. A. Tsargush6M. V. Gusev7Ya. V. Safronova8V. S. Kaimonov9A. A. Isaev10R. V. Deev11S.M. Kirov Military Medical Academy, Ministry of Defense of RussiaNorth-Western State Medical University named after I.I. Mechnikov, Ministry of Health of RussiaResearch Centre for Medical GeneticsV.A. Nasonov Research Institute of RheumatologyNorth-Western State Medical University named after I.I. Mechnikov, Ministry of Health of RussiaResearch Centre for Medical GeneticsScientific and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Department of HealthGeneticoGeneticoGeneticoGenetico; Human Stem Cell InstituteNorth-Western State Medical University named after I.I. Mechnikov, Ministry of Health of Russia; Human Stem Cell InstituteDifferential diagnosis of inflammatory myopathies with hereditary muscular dystrophies accompanied by a secondary inflammatory process is a time‑consuming clinical and pathomorphological task. In particular, false diagnosis of polymyositis in patients with dysferlinopathy reaches 25 % of cases.A 40‑year‑old female patient with a limb‑girdle phenotype of dysferlinopathy, initially diagnosed as polymyositis, is presented. The reasons that led to the erroneous diagnosis were: sporadic case; subacute onset; proximal muscle weakness; myalgia, which stopped on the glucocorticosteroid therapy; high levels of creatine phosphokinase (up to 17 times); the presence of lymphocytic‑macrophage infiltrate in the muscle biopsy and the absence of magnetic resonance imaging data in primary examination of the patient.The refractoriness of clinical and laboratory signs to complex immunosuppressive therapy was the reason for revising the muscle biopsy with typing of the inflammatory infiltrate. The predominantly unexpressed perivascular infiltrate was characterized by the predominance of macrophages and, to a lesser extent, CD4+, which indicated the secondary nature of the inflammation in the muscle observed in some hereditary muscular dystrophies. When conducting an immunohistochemical reaction, the absence of the dysferlin protein in the sarcoplasmic membrane was revealed.Whole‑exome sequencing (NGS) revealed a mutation in exon 39 of the DYSF gene (p.Gln1428Ter) in the heterozygous state, which leads to the appearance of a stop codon and premature termination of protein translation. MLPA method registered 3 copies of exons 18, 19, 20, 22, 24 of the DYSF gene.Thus, this clinical example reflects the main methodological errors and possible effects of immunosuppressive therapy in patients with dysferlinopathy.https://nmb.abvpress.ru/jour/article/view/510dysferlinopathylimb‑girdle muscular dystrophy r2dysf geneinflammatory myopathiespolymyositisimmunosuppression
spellingShingle S. N. Bardakov
A. М. Emelin
S. S. Nikitin
A. N. Khelkovskaya-Sergeeva
I. S. Limaev
A. F. Murtazina
V. A. Tsargush
M. V. Gusev
Ya. V. Safronova
V. S. Kaimonov
A. A. Isaev
R. V. Deev
Reasons for misdiagnosis of polymyositis in patients with dysferlinopathy: a clinical case
Нервно-мышечные болезни
dysferlinopathy
limb‑girdle muscular dystrophy r2
dysf gene
inflammatory myopathies
polymyositis
immunosuppression
title Reasons for misdiagnosis of polymyositis in patients with dysferlinopathy: a clinical case
title_full Reasons for misdiagnosis of polymyositis in patients with dysferlinopathy: a clinical case
title_fullStr Reasons for misdiagnosis of polymyositis in patients with dysferlinopathy: a clinical case
title_full_unstemmed Reasons for misdiagnosis of polymyositis in patients with dysferlinopathy: a clinical case
title_short Reasons for misdiagnosis of polymyositis in patients with dysferlinopathy: a clinical case
title_sort reasons for misdiagnosis of polymyositis in patients with dysferlinopathy a clinical case
topic dysferlinopathy
limb‑girdle muscular dystrophy r2
dysf gene
inflammatory myopathies
polymyositis
immunosuppression
url https://nmb.abvpress.ru/jour/article/view/510
work_keys_str_mv AT snbardakov reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT amemelin reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT ssnikitin reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT ankhelkovskayasergeeva reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT islimaev reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT afmurtazina reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT vatsargush reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT mvgusev reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT yavsafronova reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT vskaimonov reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT aaisaev reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase
AT rvdeev reasonsformisdiagnosisofpolymyositisinpatientswithdysferlinopathyaclinicalcase